Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5′ cap-modified mRNAs

Author:

Ohno Hirohisa1,Akamine Sae12,Mochizuki Megumi1,Hayashi Karin1,Akichika Shinichiro3,Suzuki Tsutomu3,Saito Hirohide1ORCID

Affiliation:

1. Center for iPS Cell Research and Application, Kyoto University , 53 Kawahara-cho, Shogoin , Sakyo-ku , Kyoto  606-8507, Japan

2. Graduate School of Medicine, Kyoto University , Yoshida-Konoe-cho, Sakyo-ku , Kyoto  606-8501, Japan

3. Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo , 7-3-1 Hongo , Bunkyo-ku , Tokyo  113-8656, Japan

Abstract

AbstractThe potential of synthetic mRNA as a genetic carrier has increased its application in scientific fields. Because the 5′ cap regulates the stability and translational activity of mRNAs, there are concerted efforts to search for and synthesize chemically-modified 5′ caps that improve the functionality of mRNA. Here, we report an easy and efficient method to synthesize functional mRNAs by modifying multiple 5′ cap analogs using a vaccinia virus-capping enzyme. We show that this enzyme can introduce a variety of GTP analogs to the 5′ end of RNA to generate 5′ cap-modified mRNAs that exhibit different translation levels. Notably, some of these modified mRNAs improve translation efficiency and can be conjugated to chemical structures, further increasing their functionality. Our versatile method to generate 5′ cap-modified mRNAs will provide useful tools for RNA therapeutics and biological research.

Funder

Japan Society for the Promotion of Science

Takeda Science Foundation

Sasakawa Scientific Research

Japan Science Society

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Japan Agency for Medical Research and Development

Research Center Network

iPS Cell Research Fund

Publisher

Oxford University Press (OUP)

Subject

Genetics

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Unleashing the potential of mRNA therapeutics for inherited neurological diseases;Brain;2024-04-25

2. Capped or uncapped? Techniques to assess the quality of mRNA molecules;Current Opinion in Systems Biology;2024-03

3. Advances and prospects of mRNA vaccines in cancer immunotherapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

4. Chemically Modified Platforms for Better RNA Therapeutics;Chemical Reviews;2024-01-29

5. Recent progress in mRNA cancer vaccines;Human Vaccines & Immunotherapeutics;2024-01-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3